Nature built complexity to support health.
We turn natural glycans into health ingredients.
From molecule to pilot scale, in under 12 months.
From molecule to pilot scale, in under 12 months.
Unlock novel glycans using our proprietary enzyme libraries and synthetic biology suite, built for high strain compatibility and rapid prototyping.
Automated robotic screening and advanced bioinformatics accelerate pathway refinement and expression efficiency.
Pilot-to-industrial fermentation powered by in-house labs and external upscaling partners for infant-grade quality.
With over millions invested, our labs feature advanced automation systems, high-throughput screening, enzyme libraries- that allow us to rapidly design glycans from idea to scale-up within 12 months
Scalable fermentation and custom biosynthetic routes turn designs into reality—ensuring consistent, efficient, and high-yield production.
From lab to market, we support formulation, clinical validation, regulatory affairs and commercialization—delivering science-backed solutions ready for global impact.
Glycans are complex carbohydrates that code the surfaces of cells, proteins, lipids and secretions in the human body: guiding how they communicate, fight infection and repair tissue.
Think of them as molecular QR codes your body reads constantly.
Pathogens and probiotics alike bind to glycans. Their structure chooses what thrives in your gut.
Specific beneficial bacteria such as Bifidobacteria use glycans such as HMOs as a food source.
Glycans also mimic pathogen-binding sites, acting as decoys to block viral or bacterial adhesion.
Glycan-based signaling continues throughout life: regulating inflammation, supporting mucosal immunity, and modulating host-microbe interactions in the gut, lungs, and urogenital tract.
Precision glycans engineering opens new frontiers in early-life nutrition and health ingredients for humans and animals alike.
Inbiose stands at the forefront of biotechnology, bringing complex carbohydrates to various applications.
Glycans are complex carbohydrates made of sugar units, but unlike simple sugars, they don't act as energy. Instead, they play regulatory roles: coating proteins, cells, and tissues to influence immunity, microbiome composition, and cellular signaling. In essence, they’re not “fuel”, they’re “instructions”.
Glycans are naturally present in whole foods like legumes, whole grains, and some fermented products. However, bioactive glycans like HMOs (human milk oligosaccharides) are unique to breast milk. They're not typical dietary carbs, they're biologically active molecules with targeted effects.
Glycans are carbohydrates, but they often attach to proteins (as glycoproteins) or lipids (as glycolipids). This combination alters how those proteins behave, influencing everything from immune signaling to cell recognition. In the body, this glycan “code” is critical to function.
Glycans, including HMOs, act as selective substrates for beneficial bacteria like Bifidobacteria. They shape early-life microbial colonization, influence immune tolerance, and help block pathogen adhesion. In adults, glycan-based ingredients are growing in their use by food and supplement brands.
Inbiose’s platform doesn’t simplify nature, it reflects it.
Our ingredients are GRAS-notified and EFSA-approved, backed by peer-reviewed studies across gut, immune, cognition and metabolic health.
Our precision fermentation platform ensures clean, cost-efficient production—from early-stage innovation to full commercial rollout.
We use infant-grade purification to ensure only the active molecule remains—ideal for infant formulas, supplements, and regulated markets.
We build with biology, not chemistry. Inbiose’s platform translates nature’s most powerful milk bioactives into scalable health solutions—clinically backed, sustainably made, and ready for real-world impact